General Information of Drug (ID: DMIM8UD)

Drug Name
AV-MEL-1
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 1 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DX06ZU

References

1 ClinicalTrials.gov (NCT03743298) Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma. U.S. National Institutes of Health.